Justera Health Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Justera Health's earnings have been declining at an average annual rate of -4.1%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been declining at an average rate of 74% per year.
Belangrijke informatie
-4.1%
Groei van de winst
18.3%
Groei van de winst per aandeel
Healthcare Groei van de industrie | -6.7% |
Inkomstengroei | -74.0% |
Rendement op eigen vermogen | n/a |
Nettomarge | -70.4% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Justera Health geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 2 | -1 | 3 | 0 |
31 Mar 24 | 1 | -2 | 4 | 0 |
31 Dec 23 | 2 | -3 | 4 | 0 |
30 Sep 23 | 5 | -3 | 3 | 0 |
30 Jun 23 | 7 | -4 | 4 | 0 |
31 Mar 23 | 11 | -6 | 5 | 0 |
31 Dec 22 | 15 | -5 | 5 | 0 |
30 Sep 22 | 15 | -11 | 5 | 0 |
30 Jun 22 | 16 | -8 | 5 | 0 |
31 Mar 22 | 17 | -5 | 4 | 0 |
31 Dec 21 | 20 | -9 | 4 | 0 |
31 Dec 20 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: VTAL is currently unprofitable.
Groeiende winstmarge: VTAL is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: VTAL is unprofitable, and losses have increased over the past 5 years at a rate of 4.1% per year.
Versnelling van de groei: Unable to compare VTAL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: VTAL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement op eigen vermogen
Hoge ROE: VTAL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.